Actively Recruiting
Impact of a Home-based Heat Therapy Intervention on Cardiometabolic Function in Adults With Type 2 Diabetes
Led by Montreal Heart Institute · Updated on 2026-05-12
44
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of home-based heat therapy on heart and metabolic health in adults with type 2 diabetes mellitus (T2DM). This study aims to see if 12 weeks of heat exposure can improve how the body handles fats after meals, insulin sensitivity, and blood vessel function. The research is motivated by previous findings in animals and humans suggesting heat therapy may help reduce blood sugar and improve vascular health, which is important because people with T2DM face a higher risk of cardiovascular diseases despite medication. Participants will be randomly assigned to one of two groups: one will soak their feet in water at a normal temperature of 36°C (thermoneutral), while the other will use hot water at 42°C. They will perform this foot bath therapy regularly over 12 weeks. This design allows comparison of the effects of heat therapy versus a control condition using thermoneutral water. Throughout the study, participants will be assessed for changes in hemoglobin A1C, insulin resistance, metabolism after meals, blood vessel function, arterial stiffness, and blood pressure from the start to the end of 12 weeks. The study includes regular monitoring and measurements to understand how heat therapy may impact cardiometabolic health in people with T2DM. The total participation period is 12 weeks, during which the intervention and assessments occur.
CONDITIONS
Brief Title
Home-based Heat Therapy for Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 45 to 75 years
- Diagnosis of type 2 diabetes mellitus for at least 1 year
- Stable medication use for at least 12 weeks
You will not qualify if you...
- Class 3 obesity
- Hypertension not controlled by medication
- Diagnosis of cardiac, renal, or pulmonary disease
- Severe neuropathy or retinopathy
- Use of insulin therapy
- Fasting plasma triglycerides greater than 5.0 mmol/L
- Fasting total cholesterol greater than 7 mmol/L
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants immerse their feet in a foot bath with either thermoneutral (36°C) or hot water (42°C) as part of the heat therapy intervention.
Regular visits during the 12-week treatment period
Trial Site Locations
Total: 1 location
1
Centre ÉPIC, Montreal Heart Institute
Montreal, Quebec, Canada, H1T1N6
Actively Recruiting
Research Team
D
Daniel Gagnon, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here